Create Alert
Watchlist

Aarti Pharmalabs Ltd.

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹7,614Cr
ROE13.69%
P/E Ratio(TTM)28.57
EPS(TTM)29.40
P/B Ratio3.83
Dividend Yield0.60%
Industry P/E34.34
Book Value219.55
Debt to Equity0.21
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Aarti Pharmalabs

Aarti Pharmalabs Limited is a manufacturer of active pharmaceutical ingredients (API), pharmaceutical intermediates, new chemical entities (NCE), and xanthine derivatives situated in India. The Company delivers contract development and manufacturing organization (CDMO) services for drug substance/NCE development and manufacturing for pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of corticosteroids, cytotoxic medicines, and oncology products. Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its range of intermediate products include Abemaciclib Intermediate, Acalabrutinib Intermediate, Afatinib Intermediate, Apalutamide Intermediate, Azathioprine Intermediate, Bosutinib Intermediate and others. Its xanthine and allied products include theophylline anhydrous, aminophylline, etophylline, and theophylline.;
Parent OrganisationAarti Pharmalabs
NSE SymbolAARTIPHARM

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
43.72%
Retail And Others
41.13%
Foreign Institutions
7.35%
Other Domestic Institutions
6.89%
Mutual Funds
0.90%

Top Mutual Funds Invested(2)

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
100.61
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.39
Emcure Pharmaceuticals
NA
(0.00%)
35.44
Wockhardt
NA
(0.00%)
-188.59